Vitamin D every day to keep the infection away?

Nutrients

Volumn 7, Issue 6, 2015, Pages 4170-4188

  De Castro Kroner, Juliana ^a   Sommer, Andrea ^a   Fabri, Mario ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Dendritic cell; Infection and immunity; Macrophage; T cell; Vitamin D

Indexed keywords

BETA DEFENSIN 2; CALCITRIOL; CATHELICIDIN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CHOLESTANETRIOL 26 MONOOXYGENASE; GAMMA INTERFERON; HEPCIDIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PARATHYROID HORMONE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNITY; INFECTION; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE INJURY; VITAMIN D DEFICIENCY; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; COMMUNICABLE DISEASE; COMPLICATION; DISEASE MODEL; IMMUNOLOGY;

BACTERIA (MICROORGANISMS);

ADAPTIVE IMMUNITY; ANIMALS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930959378     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064170     Document Type: Article

References (121)

1. Norman, A.W. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr.2008, 88, 491S–499S.
2. Hossein-nezhad, A.; Holick, M.F. Vitamin D for health: A global perspective. Mayo Clin. Proc.2013, 88, 720–755.
3. Hossein-nezhad, A.; Spira, A.; Holick, M.F. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: A randomized double-blind clinical trial. PLoS ONE 2013, 8, e58725.
4. Zhang, R.; Naughton, D.P. Vitamin D in health and disease: Current perspectives. Nutr. J. 2010, 9, 65.
5. Bikle, D.D. Vitamin D: Newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol. Metab. 2010, 21, 375–384.
6. Tsoukas, C.D.; Provvedini, D.M.; Manolagas, S.C. 1,25-dihydroxyvitamin d 3: A novel immunoregulatory hormone. Science 1984, 224, 1438–1440.
7. Hewison, M. Vitamin D and the intracrinology of innate immunity. Mol. Cell Endocrinol. 2010, 321, 103–111.
8. Lang, P.O.; Samaras, N.; Samaras, D.; Aspinall, R. How important is vitamin D in preventing infections? Osteoporos. Int. 2013, 24, 1537–1553.
9. Jeffery, L.E.; Wood, A.M.; Qureshi, O.S.; Hou, T.Z.; Gardner, D.; Briggs, Z.; Kaur, S.; Raza, K.; Sansom, D.M. Availability of 25-hydroxyvitamin D3 to apcs controls the balance between regulatory and inflammatory t cell responses. J. Immunol. 2012, 189, 5155–5164.
10. Jeffery, L.E.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O.S.; Hewison, M.; Walker, L.S.; Lammas, D.A.; Raza, K.; Sansom, D.M. 1,25-dihydroxyvitamin D3 and il-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing ctla-4 and foxp3. J. Immunol. 2009, 183, 5458–5467.
11. Chun, R.F.; Lauridsen, A.L.; Suon, L.; Zella, L.A.; Pike, J.W.; Modlin, R.L.; Martineau, A.R.; Wilkinson, R.J.; Adams, J.; Hewison, M. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 2010, 95, 3368–3376.
12. Grzybowski, A.; Pietrzak, K. Tadeusz reichstein (1897‒1996): A cofounder of modern steroid treatment in dermatology. Clin. Dermatol. 2012, 30, 243–247.
13. Kearns, M.D.; Alvarez, J.A.; Seidel, N.; Tangpricha, V. Impact of vitamin D on infectious disease.Am. J. Med. Sci. 2015, 349, 245–262.
14. Available online: http://www.ncbi.nlm.nih.gov// (accessed on 28 January 2015).
15. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C.; et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 1770–1773.
16. Liu, P.T.; Schenk, M.; Walker, V.P.; Dempsey, P.W.; Kanchanapoomi, M.; Wheelwright, M.; Vazirnia, A.; Zhang, X.; Steinmeyer, A.; Zugel, U.; et al. Convergence of il-1beta and vdr activation pathways in human tlr2/1-induced antimicrobial responses. PLoS ONE 2009, 4, e5810.
17. Fabri, M.; Stenger, S.; Shin, D.M.; Yuk, J.M.; Liu, P.T.; Realegeno, S.; Lee, H.M.; Krutzik, S.R.; Schenk, M.; Sieling, P.A.; et al. Vitamin D is required for ifn-gamma-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 2011, 3, 104ra102.
18. Klug-Micu, G.M.; Stenger, S.; Sommer, A.; Liu, P.T.; Krutzik, S.R.; Modlin, R.L.; Fabri, M. Cd40l and ifn-gamma induce an antimicrobial response against M. Tuberculosis in human monocytes. Immunology 2013, 139, 121–128.
19. Yuk, J.M.; Shin, D.M.; Lee, H.M.; Yang, C.S.; Jin, H.S.; Kim, K.K.; Lee, Z.W.; Lee, S.H.; Kim, J.M.; Jo, E.K. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host. Microbe 2009, 6, 231–243.
20. Sato, E.; Imafuku, S.; Ishii, K.; Itoh, R.; Chou, B.; Soejima, T.; Nakayama, J.; Hiromatsu, K. Vitamin D-dependent cathelicidin inhibits mycobacterium marinum infection in human monocytic cells. J. Dermatol. Sci. 2013, 70, 166–172.
21. Liu, P.T.; Wheelwright, M.; Teles, R.; Komisopoulou, E.; Edfeldt, K.; Ferguson, B.; Mehta, M.D.; Vazirnia, A.; Rea, T.H.; Sarno, E.N.; et al. Microrna-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat. Med. 2012, 18, 267–273.
22. Edfeldt, K.; Liu, P.T.; Chun, R.; Fabri, M.; Schenk, M.; Wheelwright, M.; Keegan, C.; Krutzik, S.R.; Adams, J.S.; Hewison, M.; et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. USA 2010, 107, 22593–22598.
23. Reich, K.M.; Fedorak, R.N.; Madsen, K.; Kroeker, K.I. Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review. World J. Gastroenterol. 2014, 20, 4934–4947.
24. Wang, T.T.; Dabbas, B.; Laperriere, D.; Bitton, A.J.; Soualhine, H.; Tavera-Mendoza, L.E.; Dionne, S.; Servant, M.J.; Bitton, A.; Seidman, E.G.; et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the nod2/card15-defensin beta2 innate immune pathway defective in crohn disease. J. Biol. Chem. 2010, 285, 2227–2231.
25. Gombart, A.F.; Borregaard, N.; Koeffler, H.P. Human cathelicidin antimicrobial peptide (camp) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin d3. FASEB J. 2005, 19, 1067–1077.
26. White, J.H. Vitamin D metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 2012, 13, 21–29.
27. Yim, S.; Dhawan, P.; Ragunath, C.; Christakos, S.; Diamond, G. Induction of cathelicidin in normal and cf bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 2007, 6, 403–410.
28. Peric, M.; Koglin, S.; Kim, S.M.; Morizane, S.; Besch, R.; Prinz, J.C.; Ruzicka, T.; Gallo, R.L.; Schauber, J. Il-17a enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol. 2008, 181, 8504–8512.
29. Kao, C.Y.; Chen, Y.; Thai, P.; Wachi, S.; Huang, F.; Kim, C.; Harper, R.W.; Wu, R. Il-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via jak and nf-kappab signaling pathways. J. Immunol. 2004, 173, 3482–3491.
30. Schauber, J.; Dorschner, R.A.; Coda, A.B.; Buchau, A.S.; Liu, P.T.; Kiken, D.; Helfrich, Y.R.; Kang, S.; Elalieh, H.Z.; Steinmeyer, A.; et al. Injury enhances tlr2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117, 803–811.
31. Campbell, G.R.; Spector, S.A. Vitamin D inhibits human immunodeficiency virus type 1 and mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 2012, 8, e1002689.
32. Campbell, G.R.; Spector, S.A. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 2012, 8, e1003017.
33. Schauber, J.; Oda, Y.; Buchau, A.S.; Yun, Q.C.; Steinmeyer, A.; Zugel, U.; Bikle, D.D.; Gallo, R.L. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and cd14 by 1,25-dihydroxyvitamin d3. J. Invest. Dermatol. 2008, 128, 816–824.
34. Muehleisen, B.; Bikle, D.D.; Aguilera, C.; Burton, D.W.; Sen, G.L.; Deftos, L.J.; Gallo, R.L. Pth/pthrp and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection. Sci. Transl. Med. 2012, 4, 135ra166.
35. Love, J.F.; Tran-Winkler, H.J.; Wessels, M.R. Vitamin D and the human antimicrobial peptide ll-37 enhance group a streptococcus resistance to killing by human cells. MBio 2012, 3.
36. Bacchetta, J.; Zaritsky, J.J.; Sea, J.L.; Chun, R.F.; Lisse, T.S.; Zavala, K.; Nayak, A.; Wesseling-Perry, K.; Westerman, M.; Hollis, B.W.; et al. Suppression of iron-regulatory hepcidin by vitamin D. J. Am. Soc. Nephrol. 2014, 25, 564–572.
37. Cherayil, B. J. The role of iron in the immune response to bacterial infection. Immunol. Res. 2011,50, 1–9.
38. Chun, R.F.; Liu, P.T.; Modlin, R.L.; Adams, J.S.; Hewison, M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front. Physiol. 2014, 5, 151.
39. Zhang, Y.; Leung, D.Y.; Richers, B.N.; Liu, Y.; Remigio, L.K.; Riches, D.W.; Goleva, E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting mapk phosphatase-1. J. Immunol. 2012, 188, 2127–2135.
40. Khoo, A.L.; Chai, L.Y.; Koenen, H.J.; Oosting, M.; Steinmeyer, A.; Zuegel, U.; Joosten, I.; Netea, M.G.; van der Ven, A.J. Vitamin D(3) down-regulates proinflammatory cytokine response to mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011, 55, 294–300.
41. Khoo, A.L.; Chai, L.Y.; Koenen, H.J.; Kullberg, B.J.; Joosten, I.; van der Ven, A.J.; Netea, M.G. 1,25-dihydroxyvitamin D3 modulates cytokine production induced by candida albicans: Impact of seasonal variation of immune responses. J. Infect. Dis. 2011, 203, 122–130.
42. Hewison, M. Vitamin D and the immune system: New perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 2010, 39, 365–379.
43. Avila, E.; Diaz, L.; Halhali, A.; Larrea, F. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin d receptor gene expression by 8-bromo cyclic amp in cultured human syncytiotrophoblast cells. J. Steroid. Biochem. Mol. Biol. 2004, 89, 115–119.
44. Verway, M.; Bouttier, M.; Wang, T.T.; Carrier, M.; Calderon, M.; An, B.S.; Devemy, E.; McIntosh, F.; Divangahi, M.; Behr, M.A.; et al. Vitamin D induces interleukin-1beta expression: Paracrine macrophage epithelial signaling controls m. Tuberculosis infection. PLoS Pathog. 2013, 9, e1003407.
45. Larcombe, L.; Orr, P.; Turner-Brannen, E.; Slivinski, C.R.; Nickerson, P.W.; Mookherjee, N. Effect of vitamin D supplementation on mycobacterium tuberculosis-induced innate immune responses in a canadian dene first nations cohort. PLoS ONE 2012, 7, e40692.
46. Kleijwegt, F.S.; Laban, S.; Duinkerken, G.; Joosten, A.M.; Zaldumbide, A.; Nikolic, T.; Roep, B.O. Critical role for tnf in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J. Immunol. 2010, 185, 1412–1418.
47. Unger, W.W.; Laban, S.; Kleijwegt, F.S.; van der Slik, A.R.; Roep, B.O. Induction of treg by monocyte-derived dc modulated by vitamin D3 or dexamethasone: Differential role for pd-l1. Eur. J. Immunol. 2009, 39, 3147–3159.
48. Chamorro, S.; Garcia-Vallejo, J.J.; Unger, W.W.; Fernandes, R.J.; Bruijns, S.C.; Laban, S.; Roep, B.O.; t Hart, B.A.; van Kooyk, Y. Tlr triggering on tolerogenic dendritic cells results in tlr2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 2009, 183, 2984–2994.
49. Wobke, T.K.; Sorg, B.L.; Steinhilber, D. Vitamin D in inflammatory diseases. Front. Physiol. 2014,5, 244.
50. Mahon, B.D.; Gordon, S.A.; Cruz, J.; Cosman, F.; Cantorna, M.T. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol. 2003, 134, 128–132.
51. Sigmundsdottir, H.; Pan, J.; Debes, G.F.; Alt, C.; Habtezion, A.; Soler, D.; Butcher, E.C. Dcs metabolize sunlight-induced vitamin D3 to “program” T cell attraction to the epidermal chemokine ccl27. Nat. Immunol. 2007, 8, 285–293.
52. Penna, G.; Amuchastegui, S.; Giarratana, N.; Daniel, K.C.; Vulcano, M.; Sozzani, S.; Adorini, L. 1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 2007, 178, 145–153.
53. Brennan, A.; Katz, D.R.; Nunn, J.D.; Barker, S.; Hewison, M.; Fraher, L.J.; O'Riordan, J.L. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987, 61, 457–461.
54. Hewison, M.; Freeman, L.; Hughes, S.V.; Evans, K.N.; Bland, R.; Eliopoulos, A.G.; Kilby, M.D.; Moss, P.A.; Chakraverty, R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003, 170, 5382–5390.
55. Fritsche, J.; Mondal, K.; Ehrnsperger, A.; Andreesen, R.; Kreutz, M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003, 102, 3314–3316.
56. Kundu, R.; Chain, B.M.; Coussens, A.K.; Khoo, B.; Noursadeghi, M. Regulation of cyp27b1 and cyp24a1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur. J. Immunol., 44, 1781–1790.
57. Penna, G.; Adorini, L. 1 alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive t cell activation. J. Immunol. 2000, 164, 2405–2411.
58. Piemonti, L.; Monti, P.; Sironi, M.; Fraticelli, P.; Leone, B.E.; Dal, C.E.; Allavena, P.; Di, C.V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000, 164, 4443–4451.
59. Griffin, M.D.; Lutz, W.; Phan, V.A.; Bachman, L.A.; McKean, D.J.; Kumar, R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin d receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98, 6800–6805.
60. van Halteren, A.G.; van Etten, E.; de Jong, E.C.; Bouillon, R.; Roep, B.O.; Mathieu, C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by tx527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 2002, 51, 2119–2125.
61. Berer, A.; Stockl, J.; Majdic, O.; Wagner, T.; Kollars, M.; Lechner, K.; Geissler, K.; Oehler, L. 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol.2000, 28, 575–583.
62. Pedersen, A.W.; Holmstrom, K.; Jensen, S.S.; Fuchs, D.; Rasmussen, S.; Kvistborg, P.; Claesson, M.H.; Zocca, M.B. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin. Exp. Immunol. 2009, 157, 48–59.
63. Veldman, C.M.; Cantorna, M.T.; DeLuca, H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000, 374, 334–338.
64. Provvedini, D.M.; Tsoukas, C.D.; Deftos, L.J.; Manolagas, S.C. 1,25 dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221, 1181–1183.
65. von Essen, M.R.; Kongsbak, M.; Schjerling, P.; Olgaard, K.; Odum, N.; Geisler, C. Vitamin D controls t cell antigen receptor signaling and activation of human t cells. Nat. Immunol. 2010, 11, 344–349.
66. Kongsbak, M.; von Essen, M.R.; Levring, T.B.; Schjerling, P.; Woetmann, A.; Odum, N.; Bonefeld, C.M.; Geisler, C. Vitamin D-binding protein controls t cell responses to vitamin D. BMC Immunol.2014, 15, 35.
67. Baeke, F.; Korf, H.; Overbergh, L.; van Etten, E.; Verstuyf, A.; Gysemans, C.; Mathieu, C. Human t lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol. 2010, 121, 221–227.
68. Correale, J.; Ysrraelit, M.C.; Gaitan, M.I. Immunomodulatory effects of vitamin d in multiple sclerosis. Brain 2009, 132, 1146–1160.
69. Bhalla, A.K.; Amento, E.P.; Serog, B.; Glimcher, L.H. 1,25-dihydroxyvitamin D 3 inhibits antigen-induced t cell activation. J. Immunol. 1984, 133, 1748–1754.
70. Lemire, J.M.; Adams, J.S.; Kermani-Arab, V.; Bakke, A.C.; Sakai, R.; Jordan, S.C. 1,25-dihydroxyvitamin D 3 suppresses human t helper/inducer lymphocyte activity in vitro. J. Immunol.1985, 134, 3032–3035.
71. Kongsbak, M.; von Essen, M.R.; Boding, L.; Levring, T.B.; Schjerling, P.; Lauritsen, J.P.; Woetmann, A.; Odum, N.; Bonefeld, C.M.; Geisler, C. Vitamin d up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human cd4+ t cells. PLoS ONE 2014, 9, e96695.
72. Rigby, W.F.C.; Stacy, T.; Fanger, M.W. Inhibition of t lymphocyte mitogenesis by 1,25-dihydroxyvitamin D 3 (calcitriol). J. Clin. Invest. 1984, 74, 1451–1455.
73. Rigby, W.F.; Denome, S.; Fanger, M.W. Regulation of lymphokine production and human t lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger rna. J. Clin. Invest. 1987, 79, 1659–1664.
74. Alroy, I.; Towers, T.L.; Freedman, L.P. Transcriptional repression of the interleukin-2 gene by vitamin d3: Direct inhibition of nfatp/ap-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995, 15, 5789–5799.
75. Cippitelli, M.; Santoni, A. Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol. 1998, 28, 3017–3030.
76. Rigby, W.F.; Waugh, M.; Graziano, R.F. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 1990, 76, 189–197.
77. Ikeda, U.; Wakita, D.; Ohkuri, T.; Chamoto, K.; Kitamura, H.; Iwakura, Y.; Nishimura, T. 1alpha,25-dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of th17 cells. Immunol. Lett. 2010, 134, 7–16.
78. Joshi, S.; Pantalena, L.C.; Liu, X.K.; Gaffen, S.L.; Liu, H.; Rohowsky-Kochan, C.; Ichiyama, K.; Yoshimura, A.; Steinman, L.; Christakos, S.; et al. 1,25-dihydroxyvitamin D(3) ameliorates th17 autoimmunity via transcriptional modulation of interleukin-17a. Mol. Cell Biol. 2011, 31, 3653–3669.
79. Tang, J.; Zhou, R.; Luger, D.; Zhu, W.; Silver, P.B.; Grajewski, R.S.; Su, S.B.; Chan, C.C.; Adorini, L.; Caspi, R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the th17 effector response. J. Immunol. 2009, 182, 4624–4632.
80. Palmer, M.T.; Lee, Y.K.; Maynard, C.L.; Oliver, J.R.; Bikle, D.D.; Jetten, A.M.; Weaver, C.T. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector cd4 T cells. J. Biol. Chem. 2011, 286, 997–1004.
81. Boonstra, A.; Barrat, F.J.; Crain, C.; Heath, V.L.; Savelkoul, H.F.; O’Garra, A. 1alpha,25-dihydroxyvitamin D3 has a direct effect on naive cd4(+) T cells to enhance the development of th2 cells. J. Immunol. 2001, 167, 4974–4980.
82. Barrat, F.J.; Cua, D.J.; Boonstra, A.; Richards, D.F.; Crain, C.; Savelkoul, H.F.; de Waal-Malefyt, R.; Coffman, R.L.; Hawrylowicz, C.M.; O’Garra, A. In vitro generation of interleukin 10-producing regulatory cd4(+) t cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (th1)- and th2-inducing cytokines. J. Exp. Med. 2002, 195, 603–616.
83. Pludowski, P.; Holick, M.F.; Pilz, S.; Wagner, C.L.; Hollis, B.W.; Grant, W.B.; Shoenfeld, Y.; Lerchbaum, E.; Llewellyn, D.J.; Kienreich, K.; et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 2013, 12, 976–989.
84. Baeke, F.; Korf, H.; Overbergh, L.; Verstuyf, A.; Thorrez, L.; Van Lommel, L.; Waer, M.; Schuit, F.; Gysemans, C.; Mathieu, C. The vitamin D analog, tx527, promotes a human cd4+cd25highcd127low regulatory t cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 2011, 186, 132–142.
85. Vyas, J.M.; Van der Veen, A.G.; Ploegh, H.L. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008, 8, 607–618.
86. Fabri, M.; Realegeno, S.E.; Jo, E.K.; Modlin, R.L. Role of autophagy in the host response to microbial infection and potential for therapy. Curr. Opin. Immunol. 2011, 23, 65–70.
87. Blanchet, F.P.; Piguet, V. Immunoamphisomes in dendritic cells amplify tlr signaling and enhance exogenous antigen presentation on mhc-ii. Autophagy 2010, 6, 816–818.
88. Jagannath, C.; Lindsey, D.R.; Dhandayuthapani, S.; Xu, Y.; Hunter, R.L., Jr.; Eissa, N.T. Autophagy enhances the efficacy of bcg vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 2009, 15, 267–276.
89. Deretic, V.; Saitoh, T.; Akira, S. Autophagy in infection, inflammation and immunity. Nat. Rev. Immunol. 2013, 13, 722–737.
90. Cantorna, M.T.; Hullett, D.A.; Redaelli, C.; Brandt, C.R.; Humpal-Winter, J.; Sollinger, H.W.; Deluca, H.F. 1,25-dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 1998, 66, 828–831.
91. Hullett, D.A.; Cantorna, M.T.; Redaelli, C.; Humpal-Winter, J.; Hayes, C.E.; Sollinger, H.W.; Deluca, H.F. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation 1998,66, 824–828.
92. Cantorna, M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 2010, 69, 286–289.
93. Cantorna, M.T.; Mahon, B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood.) 2004, 229, 1136–1142.
94. Whitcomb, J.P.; Deagostino, M.; Ballentine, M.; Fu, J.; Tenniswood, M.; Welsh, J.; Cantorna, M.; McDowell, M.A. The role of vitamin D and vitamin D receptor in immunity to leishmania major infection. J. Parasitol. Res. 2012, 2012, 134645.
95. Ehrchen, J.; Helming, L.; Varga, G.; Pasche, B.; Loser, K.; Gunzer, M.; Sunderkotter, C.; Sorg, C.; Roth, J.; Lengeling, A. Vitamin d receptor signaling contributes to susceptibility to infection with leishmania major. FASEB J. 2007, 21, 3208–3218.
96. Bruce, D.; Whitcomb, J.P.; August, A.; McDowell, M.A.; Cantorna, M.T. Elevated non-specific immunity and normal listeria clearance in young and old vitamin D receptor knockout mice. Int. Immunol. 2009, 21, 113–122.
97. Yang, H.F.; Zhang, Z.H.; Chang, Z.Q.; Tang, K.L.; Lin, D.Z.; Xu, J.Z. Vitamin D deficiency affects the immunity against mycobacterium tuberculosis infection in mice. Clin. Exp. Med. 2013, 13, 265–270.
98. He, Q.; Ananaba, G.A.; Patrickson, J.; Pitts, S.; Yi, Y.; Yan, F.; Eko, F.O.; Lyn, D.; Black, C.M.; Igietseme, J.U.; et al. Chlamydial infection in vitamin D receptor knockout mice is more intense and prolonged than in wild-type mice. J. Steroid. Biochem. Mol. Biol. 2013, 135, 7–14.
99. Chen, J.; Waddell, A.; Lin, Y.D.; Cantorna, M.T. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to citrobacter rodentium through modulation of innate lymphoid cells. Mucosal. Immunol. 2014, 8, 618–626.
100. Yuzefpolskiy, Y.; Baumann, F.M.; Penny, L.A.; Studzinski, G.P.; Kalia, V.; Sarkar, S. Vitamin D receptor signals regulate effector and memory cd8 T cell responses to infections in mice. J. Nutr.2014, 144, 2073–2082.
101. Bruce, D.; Ooi, J.H.; Yu, S.; Cantorna, M.T. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp. Biol. Med. (Maywood) 2010, 235, 921–927.
102. Nguyen, N.L.; Chen, K.; McAleer, J.; Kolls, J.K. Vitamin D regulation of ox40 ligand in immune responses to aspergillus fumigatus. Infect. Immun. 2013, 81, 1510–1519.
103. Enioutina, E.Y.; Bareyan, D.; Daynes, R.A. Tlr-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J. Immunol. 2009, 182, 4296–4305.
104. Enioutina, E.Y.; Bareyan, D.; Daynes, R.A. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 2007, 25, 1236–1249.
105. Kaposzta, R.; Tree, P.; Marodi, L.; Gordon, S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: Role of macrophages in host defense against candida albicans. Infect. Immun. 1998, 66, 1708–1717.
106. Lucas, R.M.; Gorman, S.; Geldenhuys, S.; Hart, P.H. Vitamin d and immunity. F1000Prime Rep.2014, 6, 118.
107. Zhao, L.J.; Zhou, Y.; Bu, F.; Travers-Gustafson, D.; Ye, A.; Xu, X.; Hamm, L.; Gorsage, D.M.; Fang, X.; Deng, H.W.; et al. Factors predicting vitamin D response variation in non-hispanic white postmenopausal women. J. Clin. Endocrinol. Metab. 2012, 97, 2699–2705.
108. Ahn, J.; Yu, K.; Stolzenberg-Solomon, R.; Simon, K.C.; McCullough, M.L.; Gallicchio, L.; Jacobs, E.J.; Ascherio, A.; Helzlsouer, K.; Jacobs, K.B.; et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010, 19, 2739–2745.
109. Wang, T.J.; Zhang, F.; Richards, J.B.; Kestenbaum, B.; van Meurs, J.B.; Berry, D.; Kiel, D.P.; Streeten, E.A.; Ohlsson, C.; Koller, D.L.; et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010, 376, 180–188.
110. Houghton, L.A.; Vieth, R. The case against ergocalciferol (vitamin D2) as a vitamin supplement.Am. J. Clin. Nutr. 2006, 84, 694–697.
111. Tai, K.; Need, A.G.; Horowitz, M.; Chapman, I.M. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008, 24, 279–285.
112. Bendik, I.; Friedel, A.; Roos, F.F.; Weber, P.; Eggersdorfer, M. Vitamin D: A critical and essential micronutrient for human health. Front. Physiol. 2014, 5, 248.
113. Holick, M.F. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004, 79, 362–371.
114. Clemens, T.L.; Adams, J.S.; Henderson, S.L.; Holick, M.F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982, 1, 74–76.
115. MacLaughlin, J.; Holick, M.F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 1985, 76, 1536–1538.
116. Vimaleswaran, K.S.; Cavadino, A.; Berry, D.J.; Whittaker, J.C.; Power, C.; Jarvelin, M.R.; Hypponen, E. Genetic association analysis of vitamin D pathway with obesity traits. Int. J. Obes. (Lond.) 2013, 37, 1399–1406.
117. Koutkia, P.; Lu, Z.; Chen, T.C.; Holick, M.F. Treatment of vitamin D deficiency due to crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 2001, 121, 1485–1488.
118. Yamshchikov, A.V.; Desai, N.S.; Blumberg, H.M.; Ziegler, T.R.; Tangpricha, V. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr. Pract. 2009, 15, 438–449.
119. Fetahu, I.S.; Hobaus, J.; Kallay, E. Vitamin D and the epigenome. Front. Physiol. 2014, 5, 164.
120. Carlberg, C. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 2014, 5, 167.
121. Carlberg, C.; Seuter, S.; de Mello, V.D.; Schwab, U.; Voutilainen, S.; Pulkki, K.; Nurmi, T.; Virtanen, J.; Tuomainen, T.P.; Uusitupa, M. Primary vitamin D target genes allow a categorization of possible benefits of vitamin D(3) supplementation. PLoS ONE 2013, 8, e71042.